Changes in plasma sialic acid PSA showed a trend towards decreased level from baseline to endpoint among patients of group I and group II, but the temporal pattern of these reductions was different among the groups.
← all excerpts
Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients.
1
—
—